Key Studies Influencing My Practice Following Washington 2017

October 20-24, 2017; Washington, DC
Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed.
Format: Audio (.mp3)
File Size: 46.24 MB
Released: November 20, 2017

Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed. (50 minutes)

Stephen A. Harrison, MD, COL (Ret.), FAASLD, has disclosed that he has received consulting fees from Axcella, Capulus, the Chronic Liver Disease Foundation, Cirius, Genfit, Echosens, Histoindex, Intercept, Madrigal, NGM Bio, Novartis, Novo Nordisk, Perspectum, and Prometheus; has received fees for non-CME/CE services from AbbVie, Alexion, and Gilead Sciences; and has an ownership interest in Cirius.

Paul Y. Kwo, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck and funds for research support from AbbVie and Gilead Sciences.

Norah Terrault, MD, MPH, has disclosed that she has received consulting fees from Gilead Sciences and Merck and funds for research support from AbbVie, Gilead Sciences, and Merck.

Acknowledgements

Educational grant provided by:
AbbVie
Gilead Sciences
Merck & Co., Inc.

Related Content

Download free expert-authored slides reviewing European HBV management recommendations for specific patient populations and learn how expert faculty approach complex cases

Maria Buti, MD person default Pietro Lampertico, MD, PhD Released: June 1, 2020

Watch this interactive presentation from CCO to learn how expert faculty would manage complex patients with HBV based on European guidelines

Commentary from Mindie H. Nguyen, MD, MAS, on hepatitis B treatment candidacy of patients in the gray zone of the AASLD practice guidance

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Released: April 6, 2020

Latest data and best practice guidance on treating HCV in addiction medicine settings published by Clinical Care Options (CCO)

Andrew Seaman, MD Released: February 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?